DR. LLOYD PAUL AIELLO, M.D., PH.D.
Medical Practice in Boston, MA
License number
Massachusetts 75315
Category
Medical Practice
Type
Ophthalmology
Address
Address
2
1 Joslin Place Joslin Diabetes Ctr, Boston, MA 02215
15 Pinehurst Rd, Belmont, MA 02478
15 Pinehurst Rd, Belmont, MA 02478
Phone
(617) 732-2520
Personal information
See more information about LLOYD PAUL AIELLO at radaris.comName
Address
Phone
15 Pinehurst Rd, Belmont, MA 02478
2 Berkeley St, Cambridge, MA 02138
2 Berkeley St #12, Cambridge, MA 02138
Cambridge, MA
212 Berkeley St, Boston, MA 02116
Organization information
See more information about LLOYD PAUL AIELLO at bizstanding.comJoslin Diabetes Center - Richard Beaser MD
1 Joslin Pl #376, Boston, MA 02215
Doing business as:
Joslin Diabetes Center - Osama Hamdy MD<br>Joslin Diabetes Center - Lloyd Paul Aiello MD<br>Joslin Diabetes Center - John A D'Elia MD<br>Joslin Diabetes Center - Jason L Gaglia MD<br>Joslin Diabetes Center - Lyle D Mitzner MD<br>Joslin Diabetes Center - Martin J Abrahamson MD<br>Joslin Diabetes Center - George S Sharuk MD<br>Joslin Diabetes Center - Joan Elaine Larrabee MD<br>Joslin Diabetes Center - Melanie P Hoenig MD<br>Joslin Diabetes Center - Elizabeth S Halprin MD<br>Joslin Diabetes Center - Jennifer K Sun MD
Site:
Phone:
(617) 732-2400 (Phone)
Categories:
Physicians & Surgeons, Ophthalmology Physicians & Surgeons, Nephrology Physicians & Surgeons, ...
In business since:
1898
Products:
Clinics, Diabetes, Endocrinology, ...
Professional information
Dr. Lloyd P Aiello, Boston MA - MD (Doctor of Medicine)
Specialties:
Ophthalmology
Address:
Beetham Eye Institute
1 Joslin Pl, Boston 02215
(617) 732-2552 (Phone)
1 Joslin Pl, Boston 02215
(617) 732-2552 (Phone)
Certifications:
Ophthalmology, 1966
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Boston University School Of Medicine
Graduated: 1988
Framingham Union Hospital
Graduated: 1989
Wilmer Opthalmological Institute
Graduated: 1992
Harvard Med School
Graduated: 1994
Boston University School Of Medicine
Graduated: 1988
Framingham Union Hospital
Graduated: 1989
Wilmer Opthalmological Institute
Graduated: 1992
Harvard Med School
Graduated: 1994
Dr. Lloyd M Aiello, Boston MA - MD (Doctor of Medicine)
Specialties:
Ophthalmology
Address:
Beetham Eye Institute
1 Joslin Pl, Boston 02215
(617) 732-2552 (Phone)
1 Joslin Pl, Boston 02215
(617) 732-2552 (Phone)
Languages:
English
Hospitals:
Beetham Eye Institute
1 Joslin Pl, Boston 02215
Beth Israel Deaconess Medical Center
330 Brookline Ave, Boston 02215
1 Joslin Pl, Boston 02215
Beth Israel Deaconess Medical Center
330 Brookline Ave, Boston 02215
Education:
Medical School
Boston University School Of Medicine
Graduated: 1960
Greenwich Hospital Conn
Graduated: 1961
Mass Ee Infirm
Graduated: 1964
Boston University School Of Medicine
Graduated: 1960
Greenwich Hospital Conn
Graduated: 1961
Mass Ee Infirm
Graduated: 1964
Methods Of Diagnosing, Treating, And Preventing Increased Vascular Permeability
US Patent:
2010011, May 13, 2010
Filed:
Jan 25, 2008
Appl. No.:
12/522625
Inventors:
Edward P. Feener - North Reading MA, US
Lloyd P. Aiello - Belmont MA, US
Lloyd P. Aiello - Belmont MA, US
Assignee:
Joslin Diabetes Center - Boston MA
International Classification:
A61K 39/395, A61K 38/00, A61K 31/155, A61K 31/662, A61K 38/07, A61K 31/415, A61K 31/42, A61K 31/35, A61K 31/433, A61P 27/02
US Classification:
4241351, 514 2, 4241581, 514637, 514143, 514 18, 4241411, 4241461, 4241331, 4241361, 424 9464, 514406, 514378, 514455, 514363
Abstract:
The present invention provides methods for the treatment and diagnosis of disorders associated with excessive vascular permeability and edema.
Methods For Treatment Of Kallikrein-Related Disorders
US Patent:
2011006, Mar 17, 2011
Filed:
Jan 30, 2009
Appl. No.:
12/865332
Inventors:
Lloyd P. Aiello - Belmont MA, US
Tamie Jo Chilcote - San Francisco CA, US
Sukanto Sinha - San Francisco CA, US
Edward P. Feener - North Reading MA, US
Tamie Jo Chilcote - San Francisco CA, US
Sukanto Sinha - San Francisco CA, US
Edward P. Feener - North Reading MA, US
Assignee:
JOSKIN DIABETES CENTER - BOSTON MA
ACTIVESITE PHARMACEUTICALS, INC. - SAN FRANCISCO CA
ACTIVESITE PHARMACEUTICALS, INC. - SAN FRANCISCO CA
International Classification:
A61K 31/4439, A61K 31/415, A61K 31/341, A61K 31/4192, A61K 31/381, A61K 31/426, A61K 31/4436, A61P 9/00, A61K 31/404, A61K 31/343, A61P 3/10, A61P 9/12, A61P 31/00, A61P 25/00
US Classification:
514343, 514406, 514461, 514359, 514448, 514365, 514336, 514419, 514469, 514443
Abstract:
We have identified classes of kallikrein inhibitors as compounds that are useful in the reduction of vascular permeability (e.g., retinal vascular permeability and cerebral vascular permeability) and astrocyte activation. Diseases and conditions associated with increased vascular permeability include diabetic retinopathy, hemorrhagic stroke, and macular edema. Diseases and conditions associated with astrocyte activation include Alzheimer's disease, multiple sclerosis, Parkinson's disease, amyotrophic lateral sclerosis, Creutzfeldt-Jakob disease, stroke, epilepsy, and brain trauma.
Systems And Methods For Detecting Retinal Abnormalities
US Patent:
2011017, Jul 14, 2011
Filed:
Oct 15, 2010
Appl. No.:
12/905929
Inventors:
Rami Mangoubi - Newton MA, US
Mukund Desai - Needham MA, US
Joseph Danko - Shrewsbury MA, US
Lloyd Paul Aiello - Belmont MA, US
Mukund Desai - Needham MA, US
Joseph Danko - Shrewsbury MA, US
Lloyd Paul Aiello - Belmont MA, US
International Classification:
G06K 9/00
US Classification:
382128
Abstract:
The invention relates to methods and systems for detecting retinal abnormalities in fundus images by interdependently smoothing and segmenting the image, identifying retinal features in the smoothed and segmented image and analyzing the identified retinal features in the smoothed and segmented image to identify a retinal abnormality.
Therapeutic Treatment For Vegf Related Ocular Diseases
US Patent:
6114320, Sep 5, 2000
Filed:
Apr 30, 1997
Appl. No.:
8/841739
Inventors:
Lloyd P. Aiello - Belmont MA
Michael R. Jirousek - Indianapolis IN
George L. King - Dover MA
Louis Vignati - Indianapolis IN
Douglas Kirk Ways - Indianapolis IN
Michael R. Jirousek - Indianapolis IN
George L. King - Dover MA
Louis Vignati - Indianapolis IN
Douglas Kirk Ways - Indianapolis IN
Assignee:
Eli Lilly and Company - Indianapolis IN
Joslin Diabetes Center - Boston MA
Joslin Diabetes Center - Boston MA
International Classification:
A61K 3133, A61K 31555
US Classification:
514185
Abstract:
A method for inhibiting VEGF stimulated endothelial cell growth, such as associated with macular degeneration, and VEGF stimulated capillary permeability, such as associated with macular edema are disclosed, particularly using the isozyme selective PKC inhibitor, (S)-3,4-[N,N'-1,1'-((2"-ethoxy)-3'"(O)-4'"-(N,N-dimethylamino)-butane)-bis -(3,3'-indoly 1)]-1(H)-pyrrole-2,5-dionehydrochloridesalt.
Therapeutic Treatment For Vegf Related Diseases
US Patent:
6284751, Sep 4, 2001
Filed:
Jun 18, 1999
Appl. No.:
9/335887
Inventors:
Lloyd P. Aiello - Belmont MA
Michael R. Jirousek - Indianapolis IN
George L. King - Dover MA
Louis Vignati - Indianapolis IN
Douglas Kirk Ways - Indianapolis IN
Michael R. Jirousek - Indianapolis IN
George L. King - Dover MA
Louis Vignati - Indianapolis IN
Douglas Kirk Ways - Indianapolis IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A61K 3133, A61K 31555, A61K 3140
US Classification:
514183
Abstract:
A method for inhibiting VEGF stimulated endothelial cell growth, such as associated with neoplasia, and VEGF stimulated capillary permeability, such as associated with pulmonary edema are disclosed, particularly using the. beta. -isozyme selective PKC inhibitor, (S)-3,4-[N,N'-1,1'-((2"-ethoxy)-3'"(O)-4'"-(N,N-dimethylamino)-butane)-bis -(3,3'-indolyl)]-1(H)-pyrrole-2,5-dionehydrochloridesalt.
Compositions And Methods For Treating Diabetic Eye Disease
US Patent:
2009006, Mar 12, 2009
Filed:
Feb 19, 2008
Appl. No.:
12/033710
Inventors:
Lloyd P. Aiello - Belmont MA, US
Edward P. Feener - North Reading MA, US
Edward P. Feener - North Reading MA, US
International Classification:
A61K 38/16, G01N 33/53, C12Q 1/68, A61P 27/02
US Classification:
514 12, 435 71, 435 6
Abstract:
The present invention provides methods and composition for the treatment and diagnosis of disorders associated with excessive retinal vascularisation and vascular permeability, e.g., diabetic retinopathy and diabetic macular edema.
Compositions And Methods For Treating Vascular Permeability
US Patent:
2008028, Nov 13, 2008
Filed:
Feb 16, 2006
Appl. No.:
11/884503
Inventors:
Edward P. Feener - North Reading MA, US
Lloyd P. Aiello - Belmont MA, US
Lloyd P. Aiello - Belmont MA, US
International Classification:
A61K 38/02, A61K 48/00, C12Q 1/00, C12Q 1/68, A61P 9/00
US Classification:
514 2, 514 44, 435 4, 435 6
Abstract:
The present invention provides methods and composition for the treatment and diagnosis of disorders associated with excessive vascular permeability and edema.